Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« SGLT2 inhibitor reduces filling pressure in HFrEF patients Next Article
Even low doses of steroids tied to higher heart-disease risk »
« SGLT2 inhibitor reduces filling pressure in HFrEF patients Next Article
Even low doses of steroids tied to higher heart-disease risk »
Related Articles
July 30, 2019
Lasmiditan: rapid onset of efficacy in acute migraine
August 27, 2019
The role of neurogenic inflammation in migraine
November 8, 2021
Long-term safety and tolerability of atogepant in migraine
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy